Since Bill C-64 passed last October, the federal government has been negotiating with the provinces and territories to sign bilateral pharmacare deals. Yet, all we’ve heard from Ontario is that the province can’t commit to sign on until it knows more.
Professionals must now witness the consumption of hydromorphone and other safer supply prescriptions—and the sudden change in rules, with little accompanying guidance has made for a lot of extra work.
After delaying a decision on their regulatory stance on PPNs in December, the OCP has once again deferred the decision to wait for more clarity on the government's approach.